Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma
Konstantinos Gousias, Theocharis Theocharous, Matthias Simon
Biomedicines (2022) Vol. 10, Iss. 3, pp. 564-564
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Unlocking the molecular mechanisms of anticancer and immunomodulatory potentials of cariprazine in triple negative breast cancer
Aleksandar Lazovic, Bojana Simović Marković, Irfan Ćorović, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117931-117931
Open Access | Times Cited: 1
Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal Cancer
Md. Ariful Islam, Md. Bayazid Hossen, Md. Abu Horaira, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1369-1369
Open Access | Times Cited: 17
Personalised therapeutic approaches to glioblastoma: A systematic review
Oliver Mowforth, Jamie Brannigan, Marc El Khoury, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood–brain–barrier in a glioblastoma model
Fatemeh Madani, Hassan Morovvati, Thomas J. Webster, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Novel Clinical Trials and Approaches in the Management of Glioblastoma
Allison R. Valerius, Lauren M. Webb, Uğur Sener
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 439-465
Closed Access | Times Cited: 5
Farnesol Inhibits Cell Viability and Activates Apoptosis in Glioma C6 Cells via Downregulating Phosphoinositide 3-kinase (PI3K)/Protein Kinase B (AKT)/Mammalian Target of Rapamycin (mTOR) Pathway
Chao Gao, Shu-Jem Su, Qi Guan, et al.
Pharmacognosy Magazine (2025)
Closed Access
Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders
Marc J. Kaufman, Edward G. Meloni
Medical Gas Research (2025)
Closed Access
Phytochemicals in Cancer Therapy: Modulating Cell Cycle, Angiogenesis, and Epithelial-Mesenchymal Transition
Sheikh Showkat Ahmad, Chandni Garg, Aashaq Hussain Bhat, et al.
Revista Brasileira de Farmacognosia (2025)
Closed Access
In silico and in vitro profiling of sphingomyelin loaded zein nanoconstructs with optimized aromatic interactions and pharmacokinetics for colon cancer therapeutics
Amit Kumar Srivastav, Jyoti Jaiswal, Pradeep Kumar Rajput, et al.
International Journal of Biological Macromolecules (2025), pp. 141845-141845
Closed Access
Minichromosome maintenance 4 plays a key role in protecting against acute kidney injury by regulating tubular epithelial cells survival and regeneration
Jing Huang, Feng Liu, Zhifeng Xu, et al.
Journal of Advanced Research (2025)
Open Access
Lipid nanoparticles for treatment of glioblastoma multiforme: current status of research and clinical translation
Mugdha Kulkarni, Karthik Nadendla, Ananth Pai, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106891-106891
Open Access
The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison between Recurrent and Non-Recurrent Patient-Derived CAFs
Nima Rastegar‐Pouyani, Vahideh Montazeri, Nikoo Marandi, et al.
Cancer Investigation (2023) Vol. 41, Iss. 7, pp. 656-671
Closed Access | Times Cited: 11
The Role of CXCL13 in GC‐1 Cell Cycle Arrest Induced by Titanium Dioxide Nanoparticles Through JAK2/STAT3 Signaling Pathway
Yuzhu Lei, Ruoyun Dong, Chun-Yan Sun, et al.
Journal of Applied Toxicology (2025)
Closed Access
Biogenically produced Gold nanoparticles containing a fluoroquinolone molecule from the cell-free extract of E. hormaechei soil isolates with anti-bacterial and anti-cancer properties
Suhana Koothradan, K. K. Elyas
Inorganic Chemistry Communications (2025), pp. 114536-114536
Closed Access
Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling
Alessia Filippone, Giovanna Casili, Sarah Adriana Scuderi, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 217-217
Open Access | Times Cited: 18
Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro
Seyed Ali Shariat Razavi, Masoumeh Taghdisi Khaboushan, Raha Jafari, et al.
Physiological Reports (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 3
Design, synthesis, and antiproliferative screening of new quinoline derivatives bearing a cis-vinyl triamide motif as apoptosis activators and EGFR-TK inhibitors
Hany M. Abd El‐Lateef, Ahmed Gaafar Ahmed Gaafar, Arwa Sultan Alqahtani, et al.
RSC Advances (2024) Vol. 14, Iss. 34, pp. 24781-24790
Open Access | Times Cited: 3
The role of BCL2L13 in glioblastoma: turning a need into a target
Joadi Jacobs, Rosa Iranpour, Amir Barzegar Behrooz, et al.
Biochemistry and Cell Biology (2023) Vol. 102, Iss. 2, pp. 127-134
Open Access | Times Cited: 7
Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations
Zhijie Wang, Xun Lu, Canlin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116237-116237
Closed Access | Times Cited: 2
Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma
Jie Liu, Yung‐Ting Chang, Yan-Yu kou, et al.
Medical Oncology (2024) Vol. 41, Iss. 9
Closed Access | Times Cited: 2
Doublecortin regulates the mitochondrial-dependent apoptosis in glioma via Rho-A/Net-1/p38-MAPK signaling
Iqra Nadeem, Han Zhou, Hong Xiaoliang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma
Juan Lu, Chengbo Yu, Qiongling Bao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Intracellular Pathways and Mechanisms of Colored Secondary Metabolites in Cancer Therapy
Ani-Simona Sevastre, Elena Victoria Manea, Oana Stefana Popescu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9943-9943
Open Access | Times Cited: 11
Combined oncolytic virotherapy gold nanoparticles as synergistic immunotherapy agent in breast cancer control
Majid S. Jabir, Ahmed Majeed Al-Shammari, Zainab O. Ali, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Exploring the Role of microRNAs in Glioma Progression, Prognosis, and Therapeutic Strategies
Omar Tluli, Mazyona Al-Maadhadi, Aisha Abdulla Al-Khulaifi, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4213-4213
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top